127 related articles for article (PubMed ID: 9227531)
1. Alkalemia reduces recovery from global cerebral ischemia by NMDA receptor-mediated mechanism.
Hurn PD; Koehler RC; Traystman RJ
Am J Physiol; 1997 Jun; 272(6 Pt 2):H2557-62. PubMed ID: 9227531
[TBL] [Abstract][Full Text] [Related]
2. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs.
Davis S; Helfaer MA; Traystman RJ; Hurn PD
Stroke; 1997 Jan; 28(1):198-204; discussion 204-5. PubMed ID: 8996512
[TBL] [Abstract][Full Text] [Related]
3. Dependence of cerebral energy phosphate and evoked potential recovery on end-ischemic pH.
Hurn PD; Koehler RC; Norris SE; Blizzard KK; Traystman RJ
Am J Physiol; 1991 Feb; 260(2 Pt 2):H532-41. PubMed ID: 1996696
[TBL] [Abstract][Full Text] [Related]
4. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs.
Kim H; Koehler RC; Hurn PD; Hall ED; Traystman RJ
Stroke; 1996 Jan; 27(1):114-21. PubMed ID: 8553386
[TBL] [Abstract][Full Text] [Related]
6. Bicarbonate conservation during incomplete cerebral ischemia with superimposed hypercapnia.
Hurn PD; Koehler RC; Norris SE; Schwentker AE; Traystman RJ
Am J Physiol; 1991 Sep; 261(3 Pt 2):H853-9. PubMed ID: 1909505
[TBL] [Abstract][Full Text] [Related]
7. The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia.
Perkins WJ; Lanier WL; Karlsson BR; Milde JH; Michenfelder JD
Brain Res; 1989 Sep; 498(1):34-44. PubMed ID: 2551456
[TBL] [Abstract][Full Text] [Related]
8. Diabetic chronic hyperglycemia and cerebral pH recovery following global ischemia in dogs.
Sieber FE; Koehler RC; Brown PR; Eleff SM; Traystman RJ
Stroke; 1994 Jul; 25(7):1449-55. PubMed ID: 8023362
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
10. Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia.
Maruki Y; Koehler RC; Kirsch JR; Blizzard KK; Traystman RJ
J Cereb Blood Flow Metab; 1995 Jan; 15(1):88-96. PubMed ID: 7798342
[TBL] [Abstract][Full Text] [Related]
11. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
12. Protection of focal cerebral ischemia by alkalinization of systemic pH.
Anderson RE; Meyer FB
Neurosurgery; 2002 Nov; 51(5):1256-65; discussion 1265-6. PubMed ID: 12383371
[TBL] [Abstract][Full Text] [Related]
13. Poor hemodynamic and metabolic recovery after global incomplete cerebral ischemia associated with short-term diabetes in dogs.
Palmon SC; Sieber FE; Brown PR; Koehler RC; Eleff SM; Traystman RJ
J Cereb Blood Flow Metab; 1995 Jul; 15(4):673-80. PubMed ID: 7790417
[TBL] [Abstract][Full Text] [Related]
14. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs.
Hurn PD; Koehler RC; Blizzard KK; Traystman RJ
Stroke; 1995 Apr; 26(4):688-94; discussion 694-5. PubMed ID: 7709418
[TBL] [Abstract][Full Text] [Related]
15. MK-801 prevents the post-ischemic cerebral hypoperfusion, but not the dysfunction of the vagal baroreflex in dogs.
Kurihara J; Sahara T; Tamaoki S; Kato H
Jpn J Pharmacol; 1992 Jun; 59(2):243-5. PubMed ID: 1434121
[TBL] [Abstract][Full Text] [Related]
16. Postischemic recovery rate of cerebral ATP, phosphocreatine, pH, and evoked potentials.
Nishijima MK; Koehler RC; Hurn PD; Eleff SM; Norris S; Jacobus WE; Traystman RJ
Am J Physiol; 1989 Dec; 257(6 Pt 2):H1860-70. PubMed ID: 2513729
[TBL] [Abstract][Full Text] [Related]
17. Effects of pentoxifylline on cerebral blood flow, metabolism, and evoked response after total cerebral ischemia in dogs.
Toung TJ; Kirsch JR; Maruki Y; Traystman RJ
Crit Care Med; 1994 Feb; 22(2):273-81. PubMed ID: 8306687
[TBL] [Abstract][Full Text] [Related]
18. The NMDA antagonist MK-801 improved metabolic recovery after 10 minutes global cerebral ischaemia in rats measured with 31 phosphorous magnetic resonance spectroscopy.
Haraldseth O; Grønås T; Southon TE; Jynge P; Gisvold SE; Unsgård G
Acta Neurochir (Wien); 1990; 106(1-2):32-6. PubMed ID: 2148665
[TBL] [Abstract][Full Text] [Related]
19. MK-801 attenuates capillary bed compression and hypoperfusion following incomplete focal cerebral ischemia.
Meyer FB; Anderson RE; Friedrich PF
J Cereb Blood Flow Metab; 1990 Nov; 10(6):895-902. PubMed ID: 2211882
[TBL] [Abstract][Full Text] [Related]
20. Tirilazad mesylate does not improve early cerebral metabolic recovery following compression ischemia in dogs.
Helfaer MA; Kirsch JR; Hurn PD; Blizzard KK; Koehler RC; Traystman RJ
Stroke; 1992 Oct; 23(10):1479-85; discussion 1485-6. PubMed ID: 1412585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
